Next Article in Journal
Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XEC
Previous Article in Journal
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults
Previous Article in Special Issue
The Effectiveness of COVID-19 Vaccines During the Pre-Omicron and Omicron Periods: A Retrospective Test-Negative Case–Control Study
 
 
Brief Report

Article Versions Notes

Vaccines 2025, 13(4), 384; https://doi.org/10.3390/vaccines13040384
Action Date Notes Link
article xml file uploaded 3 April 2025 08:39 CEST Original file -
article xml uploaded. 3 April 2025 08:39 CEST Update https://www.mdpi.com/2076-393X/13/4/384/xml
article pdf uploaded. 3 April 2025 08:39 CEST Version of Record https://www.mdpi.com/2076-393X/13/4/384/pdf
article html file updated 3 April 2025 08:43 CEST Original file https://www.mdpi.com/2076-393X/13/4/384/html
Back to TopTop